Skip to main content
SpringerLink
Log in

Scipion PKPD: an Open-Source Platform for Biopharmaceutics, Pharmacokinetics and Pharmacodynamics Data Analysis

  • Research Paper
  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

Abstract

Purpose

Biopharmaceutics examines the interrelationship of the drug’s physical/chemical properties, the dosage form (drug product) in which the drug is given, and the administration route on the rate and extent of sys- temic drug absorption. Pharmacokinetics is the study of the movement of drugs in the body. It uses mathematical models to evaluate the movement of absorption, distribution, metabolism, and excretion (ADME) within an organism. Finally, Pharmacodynamics is the analysis of how these drugs af- fect that organism. Pharmacokinetics data normally comes in samples over time of the drug concentration either in plasma or in some specific tissue. Similarly, pharmacodynamics data comes normally in samples over time of some quantity of interest (biophysical quantity like temperature, blood pres- sure, etc.). The data is submitted to a non-parametric analysis, in which a description of the observed data is reported (e.g., the Area Under the Curve), or to a parametric analysis by fitting a model (normally based on differential equations) so that prediction about future events can be made. This paper aims to introduce Scipion PKPD, an open-source platform for data analysis of this kind in the three domains (Biopharmaceutics, Pharmacokinetics, and Pharmacodynamics). The platform implements the most popular models and is open to new ones. The platform provides almost 100 different high-level operations that we call protocols.

Methods

We have developed a Python module integrated into the work- flow engine Scipion. The plugin implements the numerical analysis and meta- data handling tools to address multiple problems (see Suppl. Material for a detailed list of the tasks solved).

Results

We illustrate the use of this package with an integrative exam- ple that involves all these areas.

Conclusions

We show that the package successfully addresses these kinds of analyses. Scipion PKPD is freely available at https://github.com/cossorzano/scipion-pkpd.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Macheras P, Iliadis A. Modeling in biopharmaceutics, pharmacokinetics and pharmacodynamics: homogeneous and heterogeneous approaches, volume 30: Springer; 2016.

  2. Ṕerez-Urizar J, Granados-Soto V, Flores-Murrieta FJ, Castan˜eda- Hern’andez G. Pharmacokinetic-pharmacodynamic modeling: why?, Arch Med Res 2000;31:539–545.

  3. Gabrielsson J, Weiner D. Pharmacokinetic and pharmacodynamic data analysis: concepts and applications. 4th ed: Swedish Pharmaceutical Press; 2007.

  4. Peters SA. Physiologically-based pharmacokinetic (PBPK) modeling and simulations: principles, methods, and applications in the pharmaceutical industry: John Wiley & Sons; 2012.

  5. Duffull SB, Kirkpatrick CM, Green B, Holford NH. Analysis of population pharmacokinetic data using nonmem and winbugs. J Biopharm Stat. 2004;15:53–73.

    Article  Google Scholar 

  6. Lunn DJ, Best N, Thomas A, Wakefield J, Spiegelhalter D. Bayesian analysis of population pk/pd models: general concepts and software. J Pharmacokinet Pharmacodyn. 2002;29:271–307.

    Article  CAS  Google Scholar 

  7. Gieschke R, Serafin D. Development of innovative drugs via modeling with MATLAB: Springer; 2013.

  8. Hosseini I, Gajjala A, Yadav DB, Sukumaran S, Ramanujan S, Paxson R, et al. gpkpdsim: a simbiologyQR -based gui application for pkpd modeling in drug development. J Pharmacokinet Pharmacodyn. 2018;45:259–75.

    Article  CAS  Google Scholar 

  9. Park J-S, Kim J-R. Non-compartmental data analysis using simbiology and matlab. Transl Clin Pharmacol. 2019;27:89–91.

    Article  Google Scholar 

  10. Jonsson EN, Karlsson MO. Xpose—an s-plus based population phar- macokinetic/pharmacodynamic model building aid for nonmem. Comput Methods Programs Biomed. 1998;58:51–64.

    Article  Google Scholar 

  11. Retout S, Mentŕe F. Optimization of individual and population designs using splus. J Pharmacokinet Pharmacodyn. 2003;30:417–43.

    Article  Google Scholar 

  12. Dansirikul C, Choi M, Duffull SB. Estimation of pharmacokinetic pa- rameters from non-compartmental variables using microsoft excel. Comput Biol Med. 2005;35:389–403.

    Article  CAS  Google Scholar 

  13. Zhang Y, Huo M, Zhou J, Xie S. Pksolver: an add-in program for pharmacokinetic and pharmacodynamic data analysis in microsoft excel. Comput Methods Prog Biomed. 2010;99:306–14.

    Article  Google Scholar 

  14. Aarons L. Software for population pharmacokinetics and pharmacody- namics. Clin Pharmacokinet. 1999;36:255–64.

    Article  CAS  Google Scholar 

  15. Bauer RJ, Guzy S, Ng C. A survey of population analysis meth- ods and software for complex pharmacokinetic and pharmacodynamic models with examples. AAPS J. 2007;9:E60–83.

    Article  Google Scholar 

  16. de la Rosa-Trevín JM, Quintana A, Del Cano L, Zaldívar A, Foche I, Gutíerrez J, et al. Scipion: A software framework toward integration, reproducibility and validation in 3D electron microscopy. J Struct Biol. 2016;195:93–9.

    Article  Google Scholar 

  17. Sorzano COS, Ṕerez-De-La-Cruz Moreno MA, Burguet-Castell J, Montejo C, Aguilar Ros A. Cost-constrained optimal sampling for system identification in pharmacokinetics applications with population priors and nuisance parameters. J Pharm Sci. 2015;104:2103–9.

    Article  CAS  Google Scholar 

  18. Sorzano COS, Ṕerez-de-la Cruz Moreno MA, Martín FR, Montejo C, Aguilar A. A signal processing approach to pharmacokinetic data analysis. Pharm Re. 2021;38:625–35.

    Article  CAS  Google Scholar 

  19. Price KV, Storn RM, Lampinen JA. Differential evolution: a practical approach to global optimization. Berlin, Germany: Springer; 2005.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. National Center of Biotechnology (CSIC), c/Darwin, 3. Campus Universidad Autónoma de Madrid, 28049 Cantoblanco, Madrid, Spain

    C. O. S. Sorzano & Y. Fonseca-Reyna

  2. Kinestat Pharma, Madrid, Spain

    C. O. S. Sorzano & M. A. Pérez de la Cruz-Moreno

  3. Chemo Group, Guadalajara, Spain

    M. A. Pérez de la Cruz-Moreno

Authors
  1. C. O. S. Sorzano
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Y. Fonseca-Reyna
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. A. Pérez de la Cruz-Moreno
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to C. O. S. Sorzano.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

ESM 1

(DOCX 36 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sorzano, C.O.S., Fonseca-Reyna, Y. & de la Cruz-Moreno, M.A.P. Scipion PKPD: an Open-Source Platform for Biopharmaceutics, Pharmacokinetics and Pharmacodynamics Data Analysis. Pharm Res 38, 1169–1178 (2021). https://doi.org/10.1007/s11095-021-03065-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11095-021-03065-1

KEY WORDS

Search

Navigation